![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 08, 2010 12:30:03 PM
ABC 7 News - Hemopurifier to Rid Blood of Deadly Viruses
There could soon be a new treatment option for a million people world-wide who suffer from incurable diseases.
Scientists are working on a cartridge called the "hemopurifier" that can clean the blood by ridding it of deadly viruses and toxins.
Jeannie Gibbs has suffered from HIV for 11 years.
"It's difficult. I'm on oxygen and it takes a lot out of me. It's hard to live a normal life," Gibbs said.
The hemopurifier is not a cure for any disease, but could fill a treatment void for viruses that are drug and vaccine-resistant.
HIV patients have a limited number of drug regimens to manage their conditions and eventually they become resistant to all the drugs, and are left without options.
The hemopurifier could change that by removing the virus from the blood.
"This is a methodology to remove those mutant strains so they can stay on their drugs for extended periods of time," says Jim Joyce, of Aethlon Medical, developer of the hemopurifier.
The hemopurifier is a single-use disposable cartridge that hooks up to existing dialysis machines.
Blood enters the cartridge, travels through hollow spaghetti-looking fibers where viruses and toxins are selectively captured by small pores on the fibers' walls.
Blood circulates through the cartridge every eight minutes for about four hours.
According to Joyce, "The goal of treatment is to bridge the natural immune response to give your own response additional time to mount its own abilities to recover from infection."
Researchers believe it could benefit millions of patients with HIV, Hepatitis C and potentially cancer.
The device could also be used with a portable pump to survive bio-weapons like Ebola and smallpox or viruses like the bird flu.
"Something that would be effective against more than a single agent is logically the thing to focus our efforts on," says Dr. Charles Bailey, who is the Director of George Mason's Center of Bio defense and Infectious Diseases.
The hemopurifier is not a cure for any disease, but could fill a treatment void for viruses that are drug and vaccine resistant.
Most patients, like dialysis patients, would use the hemopurifier repeatedly.
The device is still being tested, but could be in hospitals in the next two years.
Recent AEMD News
- Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 • PR Newswire (US) • 06/21/2024 12:01:00 PM
- Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial • PR Newswire (US) • 06/18/2024 12:01:00 PM
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies • PR Newswire (US) • 06/03/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 05:24:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/17/2024 04:15:21 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/16/2024 08:05:23 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/15/2024 01:27:15 PM
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering • PR Newswire (US) • 05/15/2024 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/13/2024 09:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:01:40 PM
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma • PR Newswire (US) • 05/10/2024 12:01:00 PM
- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices • PR Newswire (US) • 02/21/2024 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:15:41 PM
- Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:15:00 PM
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 • PR Newswire (US) • 02/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:04:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:02:52 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:49:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:15:39 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM